cagrilintide tirzepatide combination study Three new phase 3 REIMAGINE studies provide some of the strongest evidence yet for CagriSema® (cagrilintide + semaglutide) in type 2 diabetes. 🔹 REIMAGINE 1 Studied people with early type 2 diabetes We are all anxiously awaiting

Description

Vitamin B12 deficiency from the perspective of a practicing hematologist Blood

For example, autistic people often value routine and predictability, while those with ADHD may become restless with repetition and seek variety, spontaneity, and new experiences

Administration is typically intravenous or intramuscular, which limits its accessibility compared to orally available or injectable peptides, but the clinical evidence supporting its use in serious neurological injury is stronger than that for almost any other peptide in this category

Methylcobalamin is the active form of vitamin B12 and can be readily utilised by the body without conversion

Faecalibacterium prausnitzii increased 41% over placebo Anaerostipes increased 67% over placebo Both bacteria are butyrate producers and their benefits are associated with butyrate production (healthy microbiome, immunity, healthy inflammatory response, etc.) Tributyrin (as CoreBiome) Is the #1 selling SCFA on the market Has clinically substantiated bioavailability in the colon In a 48-hour study using a gastrointestinal model [and that was repeated in a four-week study], CoreBiome limited IL6, TNF-alpha and measurements of epithelial function through TEER (transepithelial electrical resistance), suggesting that it may support gut barrier function Is the ONLY SCFA with marketable claims Synergy with Larazotide, Guttides (BPC-157 + KPV): Critical component of GI protocols including Guttides (BPC-157 + KPV), Larazotide and low dose pentosan polysulfate